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Abstract  
BACKGROUND: Many patients with chronic illnesses suffer from depression. A poorly controlled asthma that 
presents with repeated attacks of breathlessness is a recognised risk factor for bipolar disorders. On the other 
hand, depression can aggravate asthma symptoms.  
AIM: The aim of this study is to determine the indicators of the asthma control test (ACT) among the asthmatic 
patients who attend the outpatient clinic for follow-up and to investigate the relation between these indicators and 
clinical depression, using a standardised depression scale. 
METHODS: A total of 38 adult asthmatic patients (29 women, age 17–85 years), with variable levels of control, 
were assessed using the ACT and the Beck Depression Inventory (BDI). Data obtained were analysed with the 
Statistical Package for the Social Sciences (SPSS Inc., Chicago, IL, USA) version 20. The association of 
depression with the various indicators of asthma control was analysed with the Chi-Square test. Statistical 
significance was determined at p< 0.05. 
RESULTS: The uncontrolled asthma is associated with depression in 37% of all participants compared to 0% in 
the well-controlled group (p = 0.002). Depression is significantly related to asthma interference with daily activities 
(p = 0.003), breathlessness (p < 0.001), night symptoms (p = 0.036), use of bronchodilators (p = 0.007), and poor 
compliance with medical treatment (p = 0.003). The poor educational attainment and comorbidities have 
significant relations to both uncontrolled asthma and clinical depression (p < 0.05). 
CONCLUSION: All indicators of the poor asthma control are associated with clinical depression. A significant 
proportion of the uncontrolled asthma patients suffers from depression. The possibility of improving asthma 
control with a pharmacological treatment of depression has to be considered. 
 
 
 
Introduction 
 
Asthma is a common chronic disease that 
affects as many as 334 million people worldwide. It is 
a cause of significant burden to the affected patients, 
often undermines the quality of life, not only due to its 
physical complications but also its psychological and 
social consequences [1]. The rapidly changing 
lifestyles in the Middle East are accompanied by an 
alarming increase in the prevalence of asthma. In 
Saudi Arabia, the prevalence is approaching one-
quarter of the whole population [2]. Many factors, 
including genetic and environmental factors, appear to 
contribute to the aetiology of asthma. The factors that 
appear most important in triggering asthma 
exacerbations include dust mites, animal dander, 
cockroach particles, plant pollen, mould, viral 
infections, and certain drugs. Psychological factors 
and emotions also play a role. The airflow limitation in 
symptomatic patients is caused by contraction of the 
airway smooth muscle, vascular congestion, mucosal 
oedema and tenacious secretions. The increase in 
airway resistance causes a series of physiological and 
pathological alterations in the cardio-pulmonary 
system. Lung function tests can provide a direct 
measure of the degree of airway obstruction, but they 
may not reflect the real status of asthma control [3]. A 
disconnect between asthma control and the 
physiologic parameters of lung function has been 
suggested [3]. This indicates the presence of other 
abnormalities that may contribute to the poor 
outcomes of asthma management. Psychological 
factors, including depression, could be a possibility. 
Many patients with chronic illnesses like asthma suffer 
from depression. A poorly controlled asthma that 
presents with repeated attacks of breathlessness and 
an inability to breathe is very stressful to the patient 
and might be associated with different psychological 
disorders including panic attacks, anxiety, and 
depression [4]. The emotional stress can aggravate 
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asthma symptoms resulting in persistence of the 
depressive symptoms. A management that focuses on 
dilating the airways and neglecting the psychological 
impact of the disease is unlikely to achieve optimum 
control of the problem.  
Asthma is still underdiagnosed and 
inadequately controlled worldwide, despite effective 
treatment being available. In this country, a large 
number of asthmatic patients are not receiving 
adequate management [5]. It is important to evaluate 
the current practice of asthma management and to 
determine all factors that contribute to and associated 
with the aetiology of airway obstruction to improve 
patient's quality of life and asthma outcome.  
Many patients with chronic illnesses suffer 
from depression. A poorly controlled asthma that 
presents with repeated attacks of breathlessness is a 
recognised risk factor for bipolar disorders [6]. On the 
other hand, depression can aggravate asthma 
symptoms. The aim of this study is to determine the 
indicators of the asthma control test (ACT) among the 
asthmatic patients who attend the outpatient clinic for 
follow-up and to investigate the relation between 
these indicators and clinical depression, using a 
standardised depression scale. 
 
 
Methods 
 
A descriptive cross-sectional study was 
conducted at the outpatient respiratory clinic of King 
Khalid and King Fahd Hospitals (Tabuk, Saudi Arabia) 
between February and April 2017. The ethical 
approval was obtained from the local Ethics 
Committee at the University of Tabuk and King Fahd 
Medical City (KFMC). Facilitation letters were sent to 
the hospitals. Written consent was obtained from each 
participant before his participation. The confidentiality 
of the participants was assured. The study followed 
the principles of the Declaration of Helsinki. 
The asthmatic patients were approached 
during their follow-up visits to the outpatient 
department. Inclusion criteria were an adult (age > 15 
years old), known asthmatic for at least one year, and 
presenting for follow-up. Exclusion criteria were age ≤ 
15 years old, not known asthmatic or newly diagnosed 
(<1 year), and presenting with an acute exacerbation 
of asthma. Each participant was asked to fill an 
anonymous self-administered questionnaire that 
includes the questions of both the Beck Depression 
(BDI) Inventory [7], and Asthma Control Test (ACT) 
[8]. The BDI is a well-validated scale with a high 
sensitivity and specificity for detecting depression. It 
consists of 21 items including emotional, behavioural, 
and somatic symptoms. Each symptom is scored from 
0 to 3. The ratings of mild, moderate, and severe 
clinical depression are (10-18), (19-29) and (≥ 30), 
respectively [7]. The ACT is a well-validated and a 
reliable measure of asthma control. It is a 5-point 
scale that assesses the frequency of shortness of 
breath, general asthma symptoms, use of 
bronchodilators, the effect of asthma on daily 
activities, and an overall self-assessment of asthma 
control. The scores range from 5 (poor control of 
asthma) to 25 (complete control of asthma), with 
higher scores (20 to 25) reflecting greater asthma 
control [8]. ACT was used with kind permission from 
OPTUM Inc License No. QM040590. The obtained 
data was analysed with the Statistical Package for the 
Social Sciences (SPSS Inc., Chicago, IL, USA) 
version 20. Results were presented in the form of 
mean/ standard deviation or number's/ proportions. 
Student's t-test was used for analysis of the 
continuous variables. The association of depression 
with the various indicators of asthma control was 
analysed with the Chi-Square test. Statistical 
significance was determined at p< 0.05. 
 
 
Results 
 
A total of 38 asthma patients (76.3% females) 
participated in the study. Demographic features, 
asthma duration, and comorbidities are shown in 
Table 1. The majority (86.8%) were not working 
because they were still students or have no jobs.   
Table 1: Characteristics of participants 
Age (y) Minimum 17 
 Maximum 85 
 Mean(SD) 41.2(22.8) 
Gender (n(%)) Male 9(23.7) 
 Female 29(76.3) 
Duration of asthma (y) < 10 y 11(28.9) 
 ≥ 10 y 27(71.1) 
 Range 1-30 
 Mean(SD) 12.0(8.1) 
Education group (n(%)) Not graduated 22(57.9%) 
 Graduated 16(42.1%) 
Work group (n(%)) Working 5(13.2%) 
 Not working 33(86.8%) 
Co-morbidities (n(%)) Yes 11(28.9%) 
 No 27(71.1%) 
 
Asthma is well controlled in about one-third 
(34%) of all participants. The control has a significant 
association with a higher educational attainment of the 
participants (p < 0.001) and absence of comorbidities 
(p = 0.039). It has no relation to age, sex, work, or 
asthma duration (Table 2).  
Table 3 shows the association between 
depression and the general characteristics of the 
participants. A significant relation is found between 
depression and the educational attainment of the 
participants, with the university graduates have a 
lower prevalence of depression (3%) compared to the 
non-graduates (35%; p = 0.012).  
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Table 2: The relation of asthma control to age groups, sex, 
education, work, asthma duration, and presence of an 
additional medical illness 
Parameter 
Asthma Control  
Yes 
n (%) 
No 
n (%) 
Total P value 
Age group 
< 40 y 4 (27%) 11 (73%) 15 (100%) 0.332 
≥ 40 y 9 (39%) 14 (61%) 23 (100%)  
Sex 
Male 3 (33%) 6 (57%) 9 (100%) 0.640 
Female 10 (34%) 19 (66%) 29 (100%)  
Educational 
attainment 
Not graduated 2 (9%) 20 (91%) 22 (100%) < 0.001* 
Univ. graduate 11 (69%) 5 (31%) 16 (100%)  
Work group Working 2 (40%) 3 (60%) 5 (100%) 0.770 
Not working 11 (33%) 22 (67%) 33 (100%)  
Asthma duration 
< 10 y 3 (27%) 8 (73%) 11 (100%) 0.565 
≥ 10 y 10 (37%) 17 (63%) 27 (100%)  
Comorbidities 
Yes 1 (9%) 10 (91%) 11 (100%) 0.039* 
No 12 (44%) 15 (56%) 27 (100%)  
* Significant p-value. 
 
A significant relation is also found with the co-
morbidities (p< 0.001). Depression is more prevalent 
in asthma patients who suffer from comorbidities 
(24%) compared to those without additional chronic 
medical problems (14%). 
Table 3: The relation of depression to age groups, sex, 
education, work, asthma duration, and presence of additional 
medical illness 
Asthma control 
indicators 
Normal Mild mood 
disturbance 
Border 
depression 
Moderate 
depression 
Severe 
depression 
P value 
Age group 
< 40 y 9 (24%) 3 (8%) 1 (3%) 1 (3%) 1 (3%) 0.189 
≥ 40 y 10 (26%) 2 (5%) 0 (0%) 4 (11%) 7 (18%)  
Sex 
M 5 (13%) 2 (5%) 1 (3%) 1 (3%) 0 (0%) 0.162 
F 14 (37%) 3 (8%) 0 (0%) 4 (11%) 8 (21%)  
University 
graduate 
No 6 (16%) 3 (8%) 1 (3%) 4 (11%) 8 (21%) 
0.012* 
Yes 13 (34%) 2 (5%) 0 (0%) 1 (3%) 0 (0%)  
Working No 17 (45%) 3 (8%) 1 (3%) 4 (11%) 8 (21%) 0.305 
Yes 2 (5%) 2 (5%) 0 (0%) 1 (3%) 0 (0%)  
Asthma 
duration 
< 10 y 4 (11%) 3 (8%) 1 (3%) 2 (5%) 1 (3%) 0.151 
≥ 10 y 15 (39%) 2 (5%) 0 (0%) 3 (8%) 7 (18%)  
Co-
morbidities 
Yes 1 (3%) 1 (3%) 0 (0%) 1 (3%) 8 (21%) 0.000* 
No 18 (47%) 4 (11%) 1 (3%) 4 (11%) 0 (0%)  
* Significant p-value. 
 
Table 4 describes the association between 
depression and the indicators of asthma control. 
Depression is significantly associated with asthma 
interference with daily activities (p = 0.003), frequent 
breathlessness (p< 0.001), night symptoms (p = 
0.036), frequent use of bronchodilators (p = 0.007), 
and less compliance with medical treatment (p = 
0.003). The uncontrolled asthma is associated 
depression in 37% of all participants whereas the 
controlled asthma is associated with 0% (p = 0.002).  
Table 4: Indicators of asthma control in relation to depression 
Asthma control indicators 
Normal Mood 
disturban
ce 
Border 
depressi
on 
Moderat
e 
depressi
on 
Severe 
depressi
on 
P value 
Interference 
with work 
Mostly 8 (21%) 4 (11%) 0 (0%) 3 (8%) 7 (18%) 0.003* 
Rarely 11 (30%) 1 (3%) 1 (3%) 2 (5%) 1 (3%)  
Frequency of 
breathlessness 
≥ 3/ week 3 (8%) 4 (11%) 1 (3%) 4 (11%) 8 (21%) 
0.000* 
< 3/ week 16 (42%) 1 (3%) 0 (0%) 1 (3%) 0 (0%)  
Night symptoms 
≥ 1/ week 6 (16%) 4 (11%) 1 (3%) 5 (13%) 7 (18%) 0.036* 
< 1/ week 13 (34%) 1 (3%) 0 (0%) 0 (0%) 1 (3%)  
Frequency of 
bronchodilators 
≥ 2/ week 6 (16%) 3 (8%) 0 (0%) 4 (11%) 7 (18%) 0.007* 
< 2/ week 13 (34%) 2 (5%) 1 (3%) 1 (3%) 1 (3%)  
Compliance 
with treatment 
No 4 (11%) 5 (13%) 1 (3%) 5 (13%) 8 (21%) 0.002* 
Yes 15 (39%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)  
Overall control 
No 7 (18%) 4 (11%) 1 (3%) 5 (13%) 8 (21%) 0.005* 
Yes 12 (32%) 1 (3%) 0 (0%) 0 (0%) 0 (0%)  
* Significant p value. 
Discussion 
 
The uncontrolled asthma is a major health 
problem that imposes a negative impact on the 
country's health system and the patients' quality of 
life. In this study, asthma control has a significant 
association with a higher educational attainment of the 
participants and absence of comorbidities. This 
indicates the importance of health education as a tool 
for asthma management. It is worth noting that there 
is a paucity of data regarding the existence of health 
education for asthma patients in this country.  
In addition to the different management 
aspects that include both pharmacological and non-
pharmacological issues, the psychological impact of 
asthma is receiving an increasing worldwide attention. 
A recent study reported asthma as a risk factor for 
bipolar disease supported by suggestive evidence [6]. 
It is suggested that the evaluation of psychological as 
well as biological and adherence problems of asthma 
management might lead to a more efficient approach 
to improve the control and step down treatment in 
asthmatic patients [9]. 
A recent article presented results of seven 
years follow-up of asthma patients, who were 
investigated for the association of asthma with anxiety 
and depression, using a Hospital Anxiety & 
Depression Scale (HADS) [10]. The initial analysis 
showed depression in 14% of the participants, and the 
following analysis showed a long-term persistence of 
depression in 8% of the participants. The reported 
predictors of depression in this study were asthma 
control and lung function [10]. Similarly, in this study, 
a significant relation is found between depression and 
the educational attainment of the participants, with the 
university graduates having a lower prevalence of 
depression compared to the non-graduates. On the 
other hand, depression is more prevalent in asthma 
patients who suffer from comorbidities. The co-
morbidities increase sufferings of the patients and 
impose an additional economic burden on them and 
their families. The finding that the majority of our 
patients are not working is alarming. The most 
common co-morbidities that may accompany severe 
asthma were quite variable [11]. However, the 
assessment of patients with uncontrolled asthma to 
identify and treat the co-morbidities is likely to improve 
the overall asthma control and the quality of life [11]. 
A significant finding of this study is that all the 
indicators of asthma control, based on the Asthma 
Control Test (ACT), are significantly associated with 
clinical depression, ranging from borderline to severe 
depression. These include the interference with daily 
activities, the frequent attacks of breathlessness, the 
interruption of sleep with night symptoms, the frequent 
use of bronchodilators, and the poor compliance with 
medical treatment. It is worth noting that severe 
asthma alone might not affect the daily life physical 
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activity of the asthmatic patients, a finding that might 
consolidate the adverse effects of the psychological 
factors [12]. On the other hand, the presence of night 
symptoms that indicate a poor quality of sleep might 
be due to depression itself rather than poor asthma 
control [13]. The compliance with the pharmacological 
treatment of asthma is essential, not only for asthma 
control but also for the psychological wellbeing. 
Treating asthma is likely to minimise the depressive 
symptoms. The negative association between 
depression and treatment compliance is an 
established finding [14]. 
The study has many limitations that need to 
be considered. The sample size is small, and the 
sampling method depended on the voluntary 
participation of participants, and therefore, sampling 
bias is expected. Also, response bias is usually 
expected with the self-reporting questionnaires. 
Besides, the diagnosis of asthma was not confirmed 
with objective measurement of lung function. 
However, the used ACT and BDI are well validated 
and have high reliability.  
In conclusion, the uncontrolled asthma is 
associated with clinical depression in a significant 
proportion of asthma patients. Screening for 
depression is highly recommended, especially in the 
poorly controlled patients. The possibility of improving 
asthma control with a pharmacological treatment of 
depression has to be considered. 
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